We’re continuously expanding this Q&A library based on partner and stakeholder feedback.
Placeholder text indicates content currently under internal review and coming soon.
Learn how One Realm integrates clinical operations, analytical services, manufacturing, and logistics at the point of care.
We’re actively expanding this section. Stay tuned for insights and updates.
We’re actively expanding this section. Stay tuned for insights and updates.
We’re actively expanding this section. Stay tuned for insights and updates.
We’re actively expanding this section. Stay tuned for insights and updates.
We’re actively expanding this section. Stay tuned for insights and updates.
We’re actively expanding this section. Stay tuned for insights and updates.
Support trial execution at the point of care—REALM Bio’s clinical staff extend your team with compliant, site‑based trial management.
We work with local, regional, and global regulators to align site activation and trial readiness with established standards.
The Global Access Alliance engages directly with patients to promote awareness, education, and confidence in the care journey.
We collaborate with community leaders to co‑design programs that reflect cultural values and regional health needs.
We partner with universities and training providers to co‑develop curricula that prepare local staff to support advanced therapies.
Invest in a model that prioritizes equitable access, local capacity‑building, and long‑term impact.
Our outreach ensures alignment with ethical expectations and community trust before platform activation.
We’re actively expanding this section. Stay tuned for insights and updates.
Our facilities host third‑party analytical teams to provide independent testing services using site‑aligned instrumentation.
Each One Realm platform includes an analytical unit for diagnostics, patient screening, and GMP‑compliant testing.
We’re actively expanding this section. Stay tuned for insights and updates.
The One Realm model strengthens healthcare systems with economic development, training, and local delivery.
Our platform adapts to your cell and gene therapy process and delivers flexible manufacturing capacity based on clinical demand.
We’re actively expanding this section. Stay tuned for insights and updates.